House panel releases findings from pharmaceutical price gouging probe – Business Insider

Drug companies hiked treatments for multiple sclerosis and blood cancer, and documents showed they targeted the US market where the government can’t regulate drug prices.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here